Endoscopic submucosal dissection for the treatment of foregut neuroendocrine tumors

李全林,姚礼庆,徐美东,张轶群,钟芸诗,陈巍峰,马丽黎,秦文政,周平红
DOI: https://doi.org/10.7504/CJPS.ISSN1005-2208.2014.06.19
2014-01-01
Abstract:Objective To evaluate the feasibility and efficacy of endoscopic submucosal dissection (ESD) for foregut neuroendocrine neoplasm(NENs). Methods A total of 24 patients with confirmed histological diagnosis of foregut NENs performed ESD from April 2008 to December 2010 in Zhongshan Hospital of Fudan University were included. Tumor features, clinicopathological characteristics, complete resection rate, complications and follow-up results were evaluated. Results Those treated by ESD included 24 patients with 29 foregut NENs. The locations of the 29 lesions were as follows:esophagus (n=1), cardia (n=1), stomach (n=23), and duodenal bulb (n=4). All of the tumors were removed in an en bloc fashion. The average maximum diameter of the lesions was 9.4 mm (range 2-30 mm), and the procedure time was 20.3 min (range 10-45 min). According to the World Health Organization 2010 classification, histological evaluation determined that 26 lesions were NET-G1, 2 gastric lesions were NET-G2, and 1 esophageal lesion was neuroendocrine carcinoma (NEC). Complete resection was achieved in 28 lesions (28/29, 96.6%). The remaining patient with NEC underwent additional surgery because of incomplete resection. Delayed bleeding occurred in 1 case after ESD, which was managed by endoscopic treatment. During a mean follow-up period of 24.4 months (12-48 months), local recurrence occurred in only 1 patient after initial ESD. The patient underwent repeat ESD successfully. Metastasis to lymph nodes or distal organs was not observed in any patient. Conclusion ESD appears to be a safe, feasible and effective procedure for providing accurate histopathological evaluations as well as curative treatments for eligible foregut NENs.
What problem does this paper attempt to address?